These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37386304)

  • 1. The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal Liver Metastases.
    Shimura Y; Komatsu S; Nagatani Y; Funakoshi Y; Sofue K; Kido M; Kuramitsu K; Gon H; Fukushima K; Urade T; So S; Yanagimoto H; Toyama H; Minami H; Fukumoto T
    Ann Surg Oncol; 2023 Oct; 30(11):6603-6610. PubMed ID: 37386304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.
    Tai K; Komatsu S; Sofue K; Kido M; Tanaka M; Kuramitsu K; Awazu M; Gon H; Tsugawa D; Yanagimoto H; Toyama H; Murakami S; Murakami T; Fukumoto T
    BJS Open; 2020 Jun; 4(3):456-466. PubMed ID: 32277807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validation.
    Michiel Zeeuw J; Wesdorp NJ; Ali M; Bakker AJJ; Voigt KR; Starmans MPA; Roor J; Kemna R; van Waesberghe JHTM; van den Bergh JE; Nota IMGC; Moos SI; van Dieren S; van Amerongen MJ; Bond MJG; Chapelle T; van Dam RM; Engelbrecht MRW; Gerhards MF; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Kok NFM; Leclercq WKG; Liem MSL; van Lienden KP; Quintus Molenaar I; Patijn GA; Rijken AM; Ruers TM; de Wilt JHW; Verpalen IM; Stoker J; Grunhagen DJ; Swijnenburg RJ; Punt CJA; Huiskens J; Verhoef C; Kazemier G
    Eur J Cancer; 2024 Aug; 207():114185. PubMed ID: 38924855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of total tumor volume reduction ratio in initially unresectable colorectal liver metastases after first-line systemic treatment.
    He J; Li W; Zhou J; Sun H; Zhou C; Liu Y; Quan T; Fan W; Pan Z; Lin J; Peng J
    Eur J Radiol; 2023 Aug; 165():110950. PubMed ID: 37437437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenchymal-sparing hepatectomy for colorectal liver metastases reduces postoperative morbidity while maintaining equivalent oncologic outcomes compared to non-parenchymal-sparing resection.
    Andreou A; Gloor S; Inglin J; Di Pietro Martinelli C; Banz V; Lachenmayer A; Kim-Fuchs C; Candinas D; Beldi G
    Surg Oncol; 2021 Sep; 38():101631. PubMed ID: 34298267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term outcomes of patients undergoing hepatectomy for bilateral multiple colorectal liver metastases-a propensity score matching analysis].
    Bao Q; Wang K; Wang HW; Jin KM; Xing BC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):976-983. PubMed ID: 33053993
    [No Abstract]   [Full Text] [Related]  

  • 7. Prediction of survival in patients with colorectal liver metastases- development and validation of a prognostic score model.
    Villard C; Abdelrafee A; Habib M; Ndegwa N; Jorns C; Sparrelid E; Allard MA; Adam R
    Eur J Surg Oncol; 2022 Dec; 48(12):2432-2439. PubMed ID: 35786533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of R1 resection margin in synchronous and simultaneous colorectal liver metastasis resection: a retrospective cohort study.
    Kim NR; Alhothaifi ED; Han DH; Choi JS; Choi GH
    World J Surg Oncol; 2023 Jun; 21(1):169. PubMed ID: 37280633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total tumor volume predicts survival following liver resection in patients with hepatocellular carcinoma.
    Li MX; Zhao H; Bi XY; Li ZY; Huang Z; Han Y; Zhou JG; Zhao JJ; Zhang YF; Wei WQ; Zhao DB; Cai JQ
    Tumour Biol; 2016 Jul; 37(7):9301-10. PubMed ID: 26779628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
    Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
    J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and survival after resection of colorectal liver metastasis in the era of preoperative chemotherapy: an 11-year single-centre study.
    John SK; Robinson SM; Rehman S; Harrison B; Vallance A; French JJ; Jaques BC; Charnley RM; Manas DM; White SA
    Dig Surg; 2013; 30(4-6):293-301. PubMed ID: 23969407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
    Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
    J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
    Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
    BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nomogram predicted disease free survival for colorectal liver metastasis patients with preoperative chemotherapy followed by hepatic resection.
    Liu W; Wang K; Han Y; Liang JY; Li YH; Xing BC
    Eur J Surg Oncol; 2019 Nov; 45(11):2070-2077. PubMed ID: 31279595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Adjuvant Chemotherapy Following Curative Resection of Colorectal Cancer Liver Metastases.
    Takeda K; Kikuchi Y; Sawada YU; Kumamoto T; Watanabe J; Kuniski C; Misumi T; Endo I
    Anticancer Res; 2022 Nov; 42(11):5497-5505. PubMed ID: 36288891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximum Diameter and Number of Tumors as a New Prognostic Indicator of Colorectal Liver Metastases.
    Yoshimoto T; Morine Y; Imura S; Ikemoto T; Iwahashi S; Saito YU; Yamada S; Ishikawa D; Teraoku H; Yoshikawa M; Higashijima J; Takasu C; Shimada M
    In Vivo; 2017; 31(3):419-423. PubMed ID: 28438872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
    Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
    Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
    Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.